CLINICAL STUDY AGREEMENT PROTOCOL: OP0595-5 SITE: ME5-06-02 SPONSOR NAME: MEIJISEIKA PHARMA CO., LTD. VERSION: VERSION#1COUNTRY: CZECH REPUBLIC SMLOUVA O KLINICKÉM HODNOCENÍ PROTOKOL: OP0595-5 CENTRUM: ME5-06-02 NÁZEV ZADAVATELE: MEIJISEIKA PHARMA...Clinical Study Agreement • October 11th, 2023
Contract Type FiledOctober 11th, 2023